EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer Immunotherapy

Tesfahun Dessale Admasu iD, John S Yu

Aging Cell · 2025-05 · 24 (5)

DOI: 10.1111/acel.70055 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Aging Cell, online erschienen am 03.04.2025. Verfasst von Tesfahun Dessale Admasu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Cellular Senescence, T-Lymphocytes. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 203 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has transformed the landscape of cancer treatment, with T cell‐based strategies at the forefront of this revolution. However, the durability of these responses is frequently undermined by two intertwined phenomena: T cell exhaustion and senescence. While exhaustion is driven by chronic antigen exposure in the immunosuppressive tumor microenvironment, leading to a reversible state of diminished functionality, senescence reflects a more permanent, age‐ or stress‐induced arrest in cellular proliferation and effector capacity. Together, these processes represent formidable barriers to sustained anti‐tumor immunity. In this review, we dissect the molecular underpinnings of T cell exhaustion and senescence, revealing how these dysfunctions synergistically contribute to immune evasion and resistance across a range of solid tumors. We explore cutting‐edge therapeutic approaches aimed at rewiring the exhausted and senescent T cell phenotypes. These include advances in immune checkpoint blockade, the engineering of “armored” CAR‐T cells, senolytic therapies that selectively eliminate senescent cells, and novel interventions that reinvigorate the immune system's capacity for tumor eradication. By spotlighting emerging strategies that target both exhaustion and senescence, we provide a forward‐looking perspective on the potential to harness immune rejuvenation. This comprehensive review outlines the next frontier in cancer immunotherapy: unlocking durable responses by overcoming the immune system's intrinsic aging and exhaustion, ultimately paving the way for transformative therapeutic breakthroughs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapyCellular SenescenceT-LymphocytesRejuvenationHumansAnimalsT-Cell Senescence

Stichwörter der Autor:innen

CAR‐TT cell exhaustionT cell senescenceimmune checkpointsimmune rejuvenationimmunosenescenceimmunotherapysenolytic therapysolid tumors

Autor:innen und Institutionen

  • Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Kairos Pharma, Los Angeles, California, USA.

ORCID-Profile: Tesfahun Dessale Admasu

Zitieren

APA

Admasu, T. D., & Yu, J. S. (2025). Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer Immunotherapy. Aging Cell, 24(5). https://doi.org/10.1111/acel.70055

Vancouver

Admasu TD, Yu JS. Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer Immunotherapy. Aging Cell. 2025;24(5). doi:10.1111/acel.70055

BibTeX
@article{Admasu2025,
  author = {Admasu, Tesfahun Dessale and Yu, John S},
  title = {Harnessing Immune Rejuvenation: Advances in Overcoming T Cell Senescence and Exhaustion in Cancer Immunotherapy},
  journal = {Aging Cell},
  year = {2025},
  volume = {24},
  number = {5},
  doi = {10.1111/acel.70055}
}
Kostenlos starten →